Genomic signatures for individualized treatment of malignant tumors

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Despite advances in chemotherapy and targeted therapy, significant improvements in clinical response and survival rates for many cancers remain elusive.
• Tumor genetic heterogeneity and individual patient genetic background significantly impact treatment efficacy and prognosis.
• Current DNA microarray technology enables comprehensive gene expression analysis, leading to new tumor classifications.

Purpose of the Study:

• To review the current understanding of gene expression signatures in predicting cancer treatment response.
• To explore the potential of gene expression signatures for guiding clinical decisions.
• To discuss the future prospects of individualized cancer treatment approaches.

Main Methods:

• Review of current scientific literature on gene expression signatures in oncology.
• Analysis of studies utilizing DNA microarray technology for gene expression profiling.
• Synthesis of evidence linking gene expression patterns to treatment response and survival.

Main Results:

• Gene expression signatures can provide new molecular classifications for various tumors.
• Evidence suggests that gene expression signatures may predict patient response to chemotherapy and targeted therapies.
• Individual genetic background plays a crucial role in treatment outcomes.

Conclusions:

• Gene expression signatures hold significant potential as predictive biomarkers for cancer therapy.
• Personalized treatment strategies based on gene expression profiles could improve patient outcomes.
• Further research is warranted to fully integrate gene expression signatures into clinical decision-making.